Stahl's Essential Psychopharmacology Online
In Collaboration With
Icon Guide
 |
agomelatine (norepinephrine dopamine disinhibitor) |  |
Tips for dosing based on the clinical expertise of the author |
 |
alcohol dependence treatment |  |
Drug interactions that may occur |
 |
alpha 2 agonist |  |
Warnings and precautions regarding use of the drug |
 |
anticonvulsant |  |
Dosing and other information specific to children and adolescents |
 |
antihistamine |  |
Information regarding use of the drug during pregnancy |
 |
benzodiazepine |  |
Clinical pearls of information based on the clinical expertise of the author |
 |
cholinesterase inhibitor |  |
How the drug works, mechanism of action |
 |
conventional antipsychotic |  |
Best augmenting agents to add for partial response or treatment-resistance |
 |
dopamine stabilizer |  |
Life-threatening or dangerous side effects |
 |
lithium |  |
Weight Gain: Degrees of weight gain associated with the drug, with unusual signifying that weight gain has been reported but is not expected; not unusual signifying that weight gain occurs in a significant minority; common signifying that many experience weight gain and/or it can be significant in amount; and problematic signifying that weight gain occurs frequently, can be significant in amount, and may be a health problem in some patients |
 |
modafinil (wake-promoter) | ||
 |
monoamine oxidase inhibitor | ||
 |
nefazodone (serotonin antagonist/reuptake inhibitor) | ||
 |
nicotinic partial agonist |  |
Sedation: Degrees of sedation associated with the drug, with unusual signifying that sedation has been reported but is not expected; not unusual signifying that sedation occurs in a significant minority; common signifying that many experience sedation and/or it can be significant in amount; and problematic signifying that sedation occurs frequently, can be significant in amount, and may be a health problem in some patients |
 |
N-methyl-d-aspartate antagonist | ||
 |
noradrenergic and specific serotonergic antidepressant | ||
 |
norepinephrine and dopamine reuptake inhibitor | ||
 |
sedative hypnotic | ||
 |
selective norepinephrine reuptake inhibitor |  |
serotonin 1A partial agonist |
 |
selective serotonin reuptake inhibitor |  |
stimulant |
 |
serotonin-dopamine antagonist |  |
tricyclic/tetracyclic antidepressant |
 |
serotonin and norepinephrine reuptake inhibitor |  |
trazodone (serotonin antagonist/reuptake inhibitor) |